The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease

Abstract EN

Cardiovascular disease is the leading cause of death.

The disease is due to atherosclerosis which is characterized by lipid and fat accumulation in arterial blood vessel walls.

A key causative event is the accumulation of oxidised low density lipoprotein particles within vascular cells, and this is mediated by scavenger receptors.

One such molecule is the LOX-1 scavenger receptor that is expressed on endothelial, vascular smooth muscle, and lymphoid cells including macrophages.

LOX-1 interaction with OxLDL particles stimulates atherosclerosis.

LOX-1 mediates OxLDL endocytosis via a clathrin-independent internalization pathway.

Transgenic animal model studies show that LOX-1 plays a significant role in atherosclerotic plaque initiation and progression.

Administration of LOX-1 antibodies in cellular and animal models suggest that such intervention inhibits atherosclerosis.

Antiatherogenic strategies that target LOX-1 function using gene therapy or small molecule inhibitors would be new ways to address the increasing incidence of vascular disease in many countries.